Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 regarding Completion of tenure of Mr. Madhavan Ganesan (DIN:01674529)and Mr. Murali Sivaraman (DIN:01461231) as Non-Executive Independent Directors of theCompany
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medplus Health Services has informed the stock exchanges that the tenure of two Non-Executive Independent Directors — Mr. Madhavan Ganesan (DIN: 01674529) and Mr. Murali Sivaraman (DIN: 01461231) — has been completed, and they have ceased to be on the board. The intimation has been made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements. No reasons for departure have been disclosed beyond the natural end of their terms. The company has not announced replacements in this filing.
Two independent directors exiting the board at the same time may briefly raise governance concerns among investors, but this appears to be a routine end-of-tenure event rather than a disruptive exit. Watch for announcements on new independent director appointments to fill these vacancies.